California ADAP Access Form for Rosiglitazone (Avandia®) Use in Type 2 Diabetes TELEPHONE: [removed]FAX: [removed]After considering the available data on the cardiovascular risks of rosiglitazone ((Avandia®) th - GlaxoSmithKline - Document - PDFSEARCH.IO

First Page	Meta Content
	California ADAP Access Form for Rosiglitazone (Avandia®) Use in Type 2 Diabetes TELEPHONE: [removed]FAX: [removed]After considering the available data on the cardiovascular risks of rosiglitazone ((Avandia®) th Add to Reading List Document Date: 2012-04-20 10:50:45 Open Document File Size: 84,97 KB Share Result on Facebook Facility Pharmacy Name Phone / / / MedicalCondition Diabetes TELEPHONE / / Organization FDA / CA ADAP Medical Advisory Committee / Medicare / / / Position physician / / Product pioglitazone / Actos / Avandaryl / Avandia / Rosiglitazone / / ProvinceOrState California / / SocialTag GlaxoSmithKline Rosiglitazone Pharmaceutical sciences Eli Lilly and Company Clinical research Pioglitazone Pharmacology Informed consent Food and Drug Administration Pyridines

California ADAP Access Form for Rosiglitazone (Avandia®) Use in Type 2 Diabetes TELEPHONE: [removed]FAX: [removed]After considering the available data on the cardiovascular risks of rosiglitazone ((Avandia®) thAdd to Reading List